Reports Summarize Nephrology and Transplant Medicine Research from Koc University (SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis).

The article discusses a meta-analysis on the risk of nephrolithiasis associated with sodium-glucose co-transporter 2 (SGLT2) inhibitors, revealing a lower incidence of kidney stones in patients using these drugs compared to those receiving placebo or other active treatments. Topics include the impact of SGLT2 inhibitors on kidney stone formation, underlying mechanisms, and the need for further large-scale studies to confirm these findings.